Summary: We describe an application (Collector) for obtaining series of compounds annotated with bioactivity data, ready to be used for the development of quantitative structure-activity relationships (QSAR) models. The tool extracts data from the 'Open Pharmacological Space' (OPS) developed by the Open PHACTS project, using as input a valid name of the biological target. Collector uses the OPS ontologies for expanding the query using all known target synonyms and extracts compounds with bioactivity data against the target from multiple sources. The extracted data can be filtered to retain only drug-like compounds and the bioactivities can be automatically summarised to assign a single value per compound, yielding data ready to be used for QSAR modeling. The data obtained is locally stored facilitating the traceability and auditability of the process. Collector was used successfully for the development of models for toxicity endpoints within the eTOX project. Availability and implementation: The software is available at
Introduction
In biomedical research and, in particular, in drug development, there is an increasing need of re-using existing experimental data (Machina et al., 2013; Mons et al., 2011) . Often, this data is stored in isolated data silos, either public [ChEMBL (Gaulton et al., 2012) , UniProt (The UniProt Consortium, 2013) WikiPathways (Kelder et al., 2012), etc.] or private (e.g. pharma companies data only accessible within research consortia). Accessing public data and processing it is a complex process, involving sources with heterogeneous data formats, diverse licensing models and different levels of quality. Initiatives like FAIR (Findable, Accessible, Interoperable, Reusable) aim to overcome these issues by establishing clear principles of data management and stewardship (Wilkinson et al., 2016) .
In an attempt to mitigate this problem IMI project Open PHACTS (OPS) (Gray et al., 2014; Groth et al., 2014; Ratnam et al., 2014) built a software platform specifically designed to facilitate drug development by integrating relevant data sources using semantic web technologies (Allemang and Hendler, 2011; Berners-Lee et al., 2001; Parsons, 2009 ). The OPS platforms contains a comprehensive collection of relevant information, including (August 2017) 11 538 targets, 14 675 320 activities and 1 735 442 compounds.
One of the applications of the data obtained through OPS is the development of QSAR models, able to predict the biological properties of new compounds. The starting point for building such models is the compilation of a series of compounds (the training series) for which the bioactivity value is known. Probably the main ) and to apply customizable curation filters, producing series of compounds in a format well suited for the development of QSAR models. Thanks to the use of the OPS platform, the licensing conditions of the extracted data is very well defined (Ratnam et al., 2014) . This tool was developed as an 'exemplar application' of OPS, to be applied for developing models for predicting toxicology-related outcomes in the framework of the eTOX IMI project (Sanz et al., 2015) . Some of the models developed will be briefly described here and in full detail as Supplementary Information.
Methods and implementation
Collector works as a data extraction engine, using OPS API https:// dev.openphacts.org/. The system was developed using Scala programming language (Odersky et al., 2004) and the Play web framework (Hilton et al., 2014) . The data extracted is stored in a PostgreSQL (Stonebraker et al., 1986) https://www.postgresql.org/ local database. RDKit http://www.rdkit.org was used as a chemistry toolkit to manipulate molecular structures.
Results
In a typical Collector session, the user specifies the target of interest entering a valid identifier, like the UniprotID or the target name. During the query execution, the target identifier is expanded to search OPS for compounds annotated against this target, using any synonym term stored in the platform. The query can optionally incorporate filters for discarding compounds not meeting certain criteria, for example, Lipinski Rule of 5 (Lipinski et al., 2001) or containing unusual elements (different from H, C, N, O, S, P, Cl, I, Br, F). Other possible filters relate to the kind of biological annotation (activity, inhibition, K i or IC 50 ). The filtering protocol is customizable and the user can define additional filters for special requirements.
At execution time, the filters are applied in the sequence defined by the filtering protocol and their effect on the series size is recorded. The series obtained after each job is stored locally in a PostgreSQL database and tagged with the execution data for easy retrieval and traceability.
Often this list contains multiple annotations for the same compound. For this reason, Collector offers the possibility to aggregate all the annotations at compound level by computing the median of all the values found, thus producing a list with a single line per compound.
The series can be exported as a CSV file with the structures as SMILES, or as a SDFile with the annotations as separate fields. These files can be used directly as input in model development frameworks like eTOXlab (Carrio et al., 2015) .
Collector provides both web GUI (Fig. 1) and command line interfaces. The GUI is interactive and shows graphically the effect of the different filters on the size of the series obtained and a histogram representing the distribution of the biological property values. The structures of the compounds extracted and filtered out are also represented in an interactive table, with links to the original sources. The command line interface allows an easy integration of Collector in scripts and workflows.
Collector has been used in the eTOX project for the development of QSAR models against targets considered of toxicological interest (anti-targets). A full description of the series collected and the models developed is included as Supplementary Information. Conflict of Interest: none declared.
